Journals / Haseki Tıp Bülteni / 2015 / Cilt: 53 - Sayı: 2

Crystalloid (ringer’s solution) versus colloid 6% HES (130/0.4) for pump priming in CPB surgery

Kardiyopulmoner baypas cerrahisinde pompada başlangıç solüsyonu olarak kristalloid (ringer solüsyonu) ve kolloidlerin (%6 HES 130/0,4) karşılaştırılması

Pages
157–161
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, we concluded that HES 130/0.4 has clinical effciency and safety as a priming solution for CPB in adult patients. (The Me di cal Bul le tin of Ha se ki 2015; 53:157-61)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Various crystalloid and colloidal solutions are used to prime the cardiopulmonary bypass (CPB) system.
📊
Key Findings & Data:Methods: After the hospital scientifc committee approval, informed consent was obtained from 40 patients undergoing elective coronary artery bypass grafting (CABG).
💡
Conclusion & Impact:In this study, we concluded that HES 130/0.4 has clinical effciency and safety as a priming solution for CPB in adult patients. (The Me di cal Bul le tin of Ha se ki 2015; 53:157-61)
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Various crystalloid and colloidal solutions are used to prime the cardiopulmonary bypass (CPB) system. The aim of our study was to compare the effects of crystalloids and colloids used as priming solution during CPB. Methods: After the hospital scientifc committee approval, informed consent was obtained from 40 patients undergoing elective coronary artery bypass grafting (CABG). The patients were prospectively randomized to group 1 (n=20) receiving crystalloid as priming volume and to group 2 (n=20) receiving colloid (20 ml/ kg) 6% HES 130/0.4. Anaesthesia and CPB were standardized. Haemodynamic measurements were recorded. Laboratory parameters and plasma colloid osmotic pressures were measured. Results: Cardiac index was higher in colloid group than in crystalloid group after CPB. Plasma colloid osmotic pressure levels were lower in crystalloid group than in colloid group. Postoperative bleeding and renal function were similar in both groups. Conclusion: Crystalloids can be used as prime solution for effective haemodilution but they lack oncotic activity. In this study, we concluded that HES 130/0.4 has clinical effciency and safety as a priming solution for CPB in adult patients. (The Me di cal Bul le tin of Ha se ki 2015; 53:157-61)

Özet

Amaç: Kardiyopulmoner baypas (KPB) sisteminde başlangıç solüsyonu olarak çeşitli kristalloid ve kolloidler kullanılmaktadır. Çalışmamızın amacı, KPB sırasında başlangıç solüsyonu olarak kullanılan kristalloid ve kolloidinlerin etkilerini karşılaştırmaktır. Yöntemler: Hastane bilimsel komite onayı ve onamları alındıktan sonra elektif koroner arter baypas cerrahisi geçirecek 40 hasta çalışmaya alındı. Prospektif planlanan çalışmada hastalar randomize olarak başlangıç volümü kritalloid alacak grup 1 (n=20) ve kolloid (%6 HES 130/0,4) alacak grup 2 (n=20) olarak ikiye ayrıldı. Her iki gruba standart anestezi ve KPB yöntemi uygulandı. Hemodinamik ölçümler kaydedildi. Laboratuvar değerleri ve plazma kolloid ozmotik basınçları ölçüldü. Bulgular: KPB sonrası kardiyak indeks kolloid grubunda kristalloid grubuna göre daha yüksekti. Kolloid ozmotik basınç ise kristalloid grubunda, kolloid grubuna göre daha düşüktü. Postoperatif kanama ve renal fonksiyonlar her iki grupta benzerdi. Sonuç: Başlangıç solüsyonu olarak hemodilüsyon için kullanılan kristalloidler yetersiz onkotik aktiviteye sahiptir. Çalışmamızda bu amaçla kullanılan %6 HES 130/0,4’ün erişkin hastalarda klinik etkinliğe ve güvenirliğe sahip olduğu sonucuna vardık. (Ha se ki Tıp Bül te ni 2015; 53: 157-61)

🔖

Cite This Article

SÖĞÜT, F., KUDSİOĞLU, T., YAPICI, N., MAÇİKA, H., AYKAÇ, Z. (2015). Crystalloid (ringer’s solution) versus colloid 6% HES (130/0.4) for pump priming in CPB surgery. Haseki Tıp Bülteni, Cilt: 53 - Sayı: 2, 157–161. https://ajindex.com/articles/267849

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Gan TJ, Soppitt A, Maroof M, et al. Goal-directed intraoperative fuid administration reduces length of hospital stay after major surgery. Anestesiology 2002;97:820-6
  2. Olthof CG, Jansen PG, de Vries JP, et al. İnterstitial fuid volume during cardiak surgery measured by means of a non- invasive conductivity technique. Acta Anaesthesiol Scand 1995;39:508-12
  3. Hoeft A, Korb H, Mehlhorn U, Stephan H, Sonntag H. Priming of cardiopulmonary bypass with human albumin or Ringer lactate: effect on colloid osmotic pressure and extravascular lung water. Br J Anaesth 1991;66:73-80
  4. Eising GP, Niemeyer M,Günther T. Does a hyperoncotik cardiopulmoner bypass prime affect extavascular lung water and cardiopulmoner function in patients undergoing coroner arter bypass surgery ? Eur J Cardiothorac Surg 2001;20:282-9
  5. Niemi TT, Kuitunen AH. Hydroxyethyl starch impairs in vitro coagulation. Acta Anaesthesiol Scand 1998;42:1104-9
  6. Sade RM, Stroud MR, Crawford Jr FA, Kratz JM, Dearing JP, Bartles DM. A prospective randomized study of hydroxyethyl starch,albumin, and lactated Ringer’s solution as priming fuid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985;89:713-22
  7. Rex S, Scholz M, Weyland A, Busch T. İntra-and extravascular volume status in patients undergoing mitral valve replacement: crystalloid vs. colloid priming of cardiopulmonary bypass. European Journal of Anaesthesiology 2006;23:1-9
  8. Levy JH,Tanaka KA. İnfammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003;75:S715-S20
  9. Jarvela K, Koskinen M, Kaukinen S, Koobi T. Effect Of hypertonic saline (7,5%) on extracellular fuid volumes compared With normal saline (0,9%) and 6% hydroxyethyl starch after aortacoronary bypass graft surgery. J Cardiothorac Vasc Anaesth 2001;15:210-5
  10. Scott DA, Hore PJ, Cannata J, Masson K, Treagus B,Mullaly J. A comparison of albumin, polygeline and crystalloid priming solutions for cardiopulmonary bypass in patients having coronary artery bypass graft surgery. Perfusion 1995;10:415- 24
  11. Schmand JF, Ayain A, Morrison MH, Chaudry IH. Effect of hydroxyethyl starch after traume-hemorrhagic shock; restoration of macrophage integrity and prevention of increased circulating interleukin-6 levels. Crit Care Med 1995;23:806-14
  12. Kuitunen AH, Hynynen MJ, Vahtera E, Salmenperä MT. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg 2004;98:291-7
  13. Treib J, Baron JF, Grauer MT,